Diamyd Medical Ab
Clinical trials sponsored by Diamyd Medical Ab, explained in plain language.
-
New shot aims to keep insulin flowing in type 1 diabetes
Disease control OngoingThis study tests a drug called Diamyd in people aged 12 to 29 who were recently diagnosed with type 1 diabetes and have a specific genetic type (HLA DR3-DQ2). The goal is to see if Diamyd can help the body keep making its own insulin, which could improve blood sugar control and r…
Phase: PHASE3 • Sponsor: Diamyd Medical AB • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Could a simple injection stop type 1 diabetes before it starts?
Prevention OngoingThis phase II trial tests a drug called Diamyd, given as injections into lymph nodes, to see if it is safe and can prevent type 1 diabetes in children aged 8 to 17 who are at high risk. Only 5 participants are enrolled, and the study focuses on safety and whether the drug can sto…
Phase: PHASE2 • Sponsor: Diamyd Medical AB • Aim: Prevention
Last updated Jun 27, 2026 12:10 UTC